Thomas G Travison1, Hubert W Vesper2, Eric Orwoll3, Frederick Wu4, Jean Marc Kaufman5, Ying Wang3, Bruno Lapauw5, Tom Fiers6, Alvin M Matsumoto7, Shalender Bhasin8. 1. Institute for Aging Research, Hebrew Senior Life, and. 2. Centers for Disease Control and Prevention, Atlanta, Georgia 30341. 3. Oregon Health and Science University, Portland, Oregon 97239. 4. Andrology Research Unit, Centre for Endocrinology and Diabetes, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9WL, United Kingdom. 5. Department of Endocrinology and. 6. Department of Clinical Chemistry, Ghent University Hospital, Ghent B-9000, Belgium. 7. Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98108. 8. Research Program in Men's Health, Aging, and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Abstract
Background: Reference ranges for testosterone are essential for making a diagnosis of hypogonadism in men. Objective: To establish harmonized reference ranges for total testosterone in men that can be applied across laboratories by cross-calibrating assays to a reference method and standard. Population: The 9054 community-dwelling men in cohort studies in the United States and Europe: Framingham Heart Study; European Male Aging Study; Osteoporotic Fractures in Men Study; and Male Sibling Study of Osteoporosis. Methods: Testosterone concentrations in 100 participants in each of the four cohorts were measured using a reference method at Centers for Disease Control and Prevention (CDC). Generalized additive models and Bland-Altman analyses supported the use of normalizing equations for transformation between cohort-specific and CDC values. Normalizing equations, generated using Passing-Bablok regression, were used to generate harmonized values, which were used to derive standardized, age-specific reference ranges. Results: Harmonization procedure reduced intercohort variation between testosterone measurements in men of similar ages. In healthy nonobese men, 19 to 39 years, harmonized 2.5th, 5th, 50th, 95th, and 97.5th percentile values were 264, 303, 531, 852, and 916 ng/dL, respectively. Age-specific harmonized testosterone concentrations in nonobese men were similar across cohorts and greater than in all men. Conclusion: Harmonized normal range in a healthy nonobese population of European and American men, 19 to 39 years, is 264 to 916 ng/dL. A substantial proportion of intercohort variation in testosterone levels is due to assay differences. These data demonstrate the feasibility of generating harmonized reference ranges for testosterone that can be applied to assays, which have been calibrated to a reference method and calibrator.
Background: Reference ranges for testosterone are essential for making a diagnosis of hypogonadism in men. Objective: To establish harmonized reference ranges for total testosterone in men that can be applied across laboratories by cross-calibrating assays to a reference method and standard. Population: The 9054 community-dwelling men in cohort studies in the United States and Europe: Framingham Heart Study; European Male Aging Study; Osteoporotic Fractures in Men Study; and Male Sibling Study of Osteoporosis. Methods:Testosterone concentrations in 100 participants in each of the four cohorts were measured using a reference method at Centers for Disease Control and Prevention (CDC). Generalized additive models and Bland-Altman analyses supported the use of normalizing equations for transformation between cohort-specific and CDC values. Normalizing equations, generated using Passing-Bablok regression, were used to generate harmonized values, which were used to derive standardized, age-specific reference ranges. Results: Harmonization procedure reduced intercohort variation between testosterone measurements in men of similar ages. In healthy nonobese men, 19 to 39 years, harmonized 2.5th, 5th, 50th, 95th, and 97.5th percentile values were 264, 303, 531, 852, and 916 ng/dL, respectively. Age-specific harmonized testosterone concentrations in nonobese men were similar across cohorts and greater than in all men. Conclusion: Harmonized normal range in a healthy nonobese population of European and American men, 19 to 39 years, is 264 to 916 ng/dL. A substantial proportion of intercohort variation in testosterone levels is due to assay differences. These data demonstrate the feasibility of generating harmonized reference ranges for testosterone that can be applied to assays, which have been calibrated to a reference method and calibrator.
Authors: Katleen Van Uytfanghe; Dietmar Stöckl; Jean M Kaufman; Tom Fiers; H Alec Ross; André P De Leenheer; Linda M Thienpont Journal: Clin Chem Date: 2004-09-16 Impact factor: 8.327
Authors: Bruno M Lapauw; Youri Taes; Veerle Bogaert; Griet Vanbillemont; Stefan Goemaere; Hans-Georg Zmierczak; Dirk De Bacquer; Jean-Marc Kaufman Journal: J Bone Miner Res Date: 2009-06 Impact factor: 6.741
Authors: Giulia Rastrelli; Emma L Carter; Tomas Ahern; Joseph D Finn; Leen Antonio; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Brian Keevil; Mario Maggi; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Frederick C W Wu Journal: J Clin Endocrinol Metab Date: 2015-05-22 Impact factor: 5.958
Authors: Heather J Litman; Shalender Bhasin; Carol L Link; Andre B Araujo; John B McKinlay Journal: J Clin Endocrinol Metab Date: 2006-08-15 Impact factor: 5.958
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: Thomas G Travison; Andre B Araujo; Varant Kupelian; Amy B O'Donnell; John B McKinlay Journal: J Clin Endocrinol Metab Date: 2006-12-05 Impact factor: 5.958
Authors: Wael A Salameh; Mildred M Redor-Goldman; Nigel J Clarke; Richard E Reitz; Michael P Caulfield Journal: Steroids Date: 2009-11-17 Impact factor: 2.668
Authors: R Matthew Coward; Christy Stetter; Allen Kunselman; J C Trussell; Mark C Lindgren; Ruben R Alvero; Peter Casson; Gregory M Christman; Christos Coutifaris; Michael P Diamond; Karl R Hansen; Stephen A Krawetz; Richard S Legro; Randal D Robinson; James F Smith; Anne Z Steiner; Robert A Wild; Heping Zhang; Nanette Santoro Journal: J Urol Date: 2019-07-08 Impact factor: 7.450
Authors: Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi Journal: Nat Rev Dis Primers Date: 2019-05-30 Impact factor: 52.329
Authors: Peter J Snyder; Shalender Bhasin; Glenn R Cunningham; Alvin M Matsumoto; Alisa J Stephens-Shields; Jane A Cauley; Thomas M Gill; Elizabeth Barrett-Connor; Ronald S Swerdloff; Christina Wang; Kristine E Ensrud; Cora E Lewis; John T Farrar; David Cella; Raymond C Rosen; Marco Pahor; Jill P Crandall; Mark E Molitch; Susan M Resnick; Matthew Budoff; Emile R Mohler; Nanette K Wenger; Harvey Jay Cohen; Stanley Schrier; Tony M Keaveny; David Kopperdahl; David Lee; Denise Cifelli; Susan S Ellenberg Journal: Endocr Rev Date: 2018-06-01 Impact factor: 19.871
Authors: J C Trussell; R Matthew Coward; Nanette Santoro; Christy Stetter; Allen Kunselman; Michael P Diamond; Karl R Hansen; Stephen A Krawetz; Richard S Legro; Dan Heisenleder; James Smith; Anne Steiner; Robert Wild; Peter Casson; Cristos Coutifaris; Reuben R Alvero; R B Robinson; Greg Christman; Pasquale Patrizio; Heping Zhang; Mark C Lindgren Journal: Fertil Steril Date: 2019-04-12 Impact factor: 7.329
Authors: Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; Karin Darakananda; Emily C Gentile; David W Goldstein; Sarah H Prizand; Laura M Krivicich; Alexander P Taylor; Kendra E Wulczyn; Benjamin Z Leder; Elaine W Yu Journal: J Clin Endocrinol Metab Date: 2020-08-01 Impact factor: 5.958